Source: Annual Congress 2006 - Respiratory muscles
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. H. Remels, H. R. Gosker, P. Schrauwen, J. Willems, R. Broekhuizen, S. Kersten, A. M. Schols (Maastricht, Wageningen, Netherlands). Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 2148

Member's Comments

No comment yet.

Related content which might interest you: Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Source: Eur Respir J 2008; 31: 502-508 Year: 2008 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir Rev 2006; 15: 211-212 Year: 2006 Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD Source: Eur Respir J 2007; 30: 245-252 Year: 2007 The effects of exercise training on peroxisome proliferator-activated receptor (PPAR) expression in skeletal muscle in COPD Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation Year: 2009 The effect of COPD on muscle structure and function Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles Year: 2006 Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Respiratory and skeletal muscles in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201 Year: 2006 Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Effect of pulmonary rehabilitation on muscle inflammation and muscle insulin-like growth factor-I in COPD Source: Annual Congress 2006 - Physiological responses to rehabilitation Year: 2006 Carnitine deficiency in chronic obstructive pulmonary disease patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Vitamin D receptor genotypes influence quadriceps strength in COPD Source: Annual Congress 2007 - Pathophysiology of respiratory muscles Year: 2007 Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 617-625 Year: 2002 Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 The influence of comorbid factors on muscle function, morphology and metabolism in COPD Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=99 Year: 2003 Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD? Source: Eur Respir J 2007; 30: 191-193 Year: 2007 Systemic inflammation is associated with mitophagy signalling in skeletal muscle of COPD patients Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 52S-63S Year: 2003